# Effectiveness of 'Nexpowder' for Hemostatic Treatments of Nonvariceal, Upper Gastrointestinal Bleeding

> **NCT04124588** · NA · COMPLETED · sponsor: **Next Biomedical Co., Ltd.** · enrollment: 348 (actual)

## Conditions studied

- Nonvariceal Upper Gastrointestinal Bleeding

## Interventions

- **DEVICE:** Nexpowder (Hemostatic powder)
- **DEVICE:** Conventional Technique

## Key facts

- **NCT ID:** NCT04124588
- **Lead sponsor:** Next Biomedical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-01
- **Primary completion:** 2021-10-12
- **Final completion:** 2021-11-11
- **Target enrollment:** 348 (ACTUAL)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04124588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04124588, "Effectiveness of 'Nexpowder' for Hemostatic Treatments of Nonvariceal, Upper Gastrointestinal Bleeding". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04124588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*